Skip to main content

Published locations for Moderate-to-severe atopic dermatitis: Abrocitinib shows promise in patients who switch from dupilumab

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Moderate-to-severe atopic dermatitis: Abrocitinib shows promise in patients who switch from dupilumab

User login

  • Reset your password
  • /content/moderate-severe-atopic-dermatitis-abrocitinib-shows-promise-patients-who-switch-dupilumab
  • /dermatology/article/254737/atopic-dermatitis/moderate-severe-atopic-dermatitis-abrocitinib-shows